L&G Healthcare Breakthrough UCITS ETF (DOCG.L) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with DOCG.L. Use the tables to find lower-cost options, better risk-adjusted returns, or a closer substitute for your current allocation.
Cheapest Alternatives to DOCG.L
DOCG.L charges 0.49% annually. There are 20 ETFs in the Health & Biotech Equities category with lower expense ratios, going as low as 0.12%.
| Symbol | Name | Expense Ratio | AUM | Inception | |
|---|---|---|---|---|---|
| Xtrackers MSCI USA Health Care UCITS ETF 1D | 0.12% | 619.95M | Sep 2017 | DOCG.L vs XSHC.L | |
| Invesco US Health Care Sector UCITS ETF | 0.14% | 345.84M | Dec 2009 | DOCG.L vs XLVP.L | |
| Invesco Health Care S&P US Select Sector UCITS ETF... | 0.14% | 457.64M | Dec 2009 | DOCG.L vs XLVS.L | |
| iShares S&P 500 Health Care Sector UCITS ETF USD (... | 0.15% | 2.60B | Nov 2015 | DOCG.L vs IUHC.L | |
| SPDR S&P US Health Care Select Sector UCITS ETF | 0.15% | — | Jul 2015 | DOCG.L vs GXLV.L |
Best Risk-Adjusted Alternatives to DOCG.L
DOCG.L has a PortfoliosLab risk / return rank of 57. There are 7 ETFs in the Health & Biotech Equities category with higher risk-adjusted ranks, going as high as 93.
| Symbol | Name | Risk / Return Rank | AUM | Inception | |
|---|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF | 93 | 687.60M | Oct 2017 | DOCG.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | 89 | 55.15M | Mar 2018 | DOCG.L vs BTEE.L | |
| Invesco Nasdaq Biotech UCITS ETF | 89 | 422.07M | Nov 2014 | DOCG.L vs SBIO.L | |
| First Trust NYSE Arca Biotechnology UCITS ETF Acc | 85 | 8.49M | May 2020 | DOCG.L vs FBT.L | |
| Global X Genomics & Biotechnology UCITS ETF | 82 | 24.42M | Nov 2021 | DOCG.L vs GNOG.L |
Top Performing DOCG.L Alternatives (YTD)
DOCG.L is at 5.88% YTD. There are 8 ETFs in the Health & Biotech Equities category with higher YTD returns, going as high as 22.94%.
| Symbol | Name | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|
| Global X Genomics & Biotechnology UCITS ETF | 22.94% | 24.42M | Nov 2021 | DOCG.L vs GNOG.L | |
| WisdomTree BioRevolution UCITS ETF USD Acc | 20.51% | 14.46M | Dec 2021 | DOCG.L vs WBIO.L | |
| First Trust NYSE Arca Biotechnology UCITS ETF Acc | 18.92% | 8.49M | May 2020 | DOCG.L vs FBT.L | |
| iShares Nasdaq US Biotechnology UCITS ETF | 14.42% | 687.60M | Oct 2017 | DOCG.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | 12.25% | 55.15M | Mar 2018 | DOCG.L vs BTEE.L |
Lowest Volatility Alternatives to DOCG.L
DOCG.L has 20.26% 1-year volatility. There are 21 ETFs in the Health & Biotech Equities category with lower 1-year volatility, going as low as 13.91%.
| Symbol | Name | Volatility 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| SPDR MSCI World Health Care UCITS ETF | 13.91% | — | Apr 2016 | DOCG.L vs HEAW.L | |
| Xtrackers MSCI World Health Care UCITS ETF 1C | 14.87% | 3.33B | Mar 2016 | DOCG.L vs XDWH.L | |
| SPDR S&P US Health Care Select Sector UCITS ETF | 14.94% | — | Jul 2015 | DOCG.L vs GXLV.L | |
| Xtrackers MSCI USA Health Care UCITS ETF 1D | 15.06% | 619.95M | Sep 2017 | DOCG.L vs XSHC.L | |
| Invesco US Health Care Sector UCITS ETF | 15.09% | 345.84M | Dec 2009 | DOCG.L vs XLVP.L |
Lowest Drawdown Alternatives to DOCG.L
DOCG.L has a 1-year max drawdown of -15.84%. There are 21 ETFs in the Health & Biotech Equities category with shallower 1-year drawdowns, going as shallow as -6.89%.
| Symbol | Name | Max Drawdown 1Y | AUM | Inception | |
|---|---|---|---|---|---|
| iShares Nasdaq US Biotechnology UCITS ETF | -6.89% | 687.60M | Oct 2017 | DOCG.L vs BTEK.L | |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dis... | -7.64% | 55.15M | Mar 2018 | DOCG.L vs BTEE.L | |
| Invesco Nasdaq Biotech UCITS ETF | -7.65% | 422.07M | Nov 2014 | DOCG.L vs SBIO.L | |
| L&G Pharma Breakthrough UCITS ETF | -9.93% | 14.36M | Jan 2018 | DOCG.L vs BIGT.L | |
| Xtrackers MSCI World Health Care UCITS ETF 1C | -10.39% | 3.33B | Mar 2016 | DOCG.L vs XDWH.L |
Other ETFs from Legal & General
The 10 most viewed Legal & General ETFs shown here include LGGG.L, AIAI.L, AIAG.L and span 8 categories. AUM among these funds goes as high as $2B.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|---|---|
| L&G Global Equity UCITS ETF | Global Equities | 86 | 9.76% | 984.93M | Nov 2018 | DOCG.L vs LGGG.L | |
| L&G Artificial Intelligence UCITS ETF | Technology Equities | 74 | 34.10% | 1.72B | Jun 2019 | DOCG.L vs AIAI.L | |
| L&G Artificial Intelligence UCITS ETF | Technology Equities | 79 | 36.61% | 1.30B | Jun 2019 | DOCG.L vs AIAG.L | |
| L&G Gold Mining UCITS ETF | Gold, Precious Metals | 34 | -10.22% | 640.97M | Nov 2008 | DOCG.L vs AUCP.L | |
| L&G Quality Equity Dividends ESG Exclusions Europe... | Europe Equities | 87 | 11.36% | 301.52M | Apr 2021 | DOCG.L vs LDEG.L | |
| L&G All Commodities UCITS ETF | Commodities | 52 | 16.06% | 323.48M | Jul 2017 | DOCG.L vs BCOG.L | |
| L&G ROBO Global Robotics and Automation UCITS ETF | Robotics, Technology Equities | 76 | 22.06% | 1.03B | Oct 2014 | DOCG.L vs ROBG.L | |
| L&G Clean Water UCITS ETF | Water Equities | 29 | 7.41% | 508.54M | Jun 2019 | DOCG.L vs GLGG.L | |
| L&G UK Equity UCITS ETF | Europe Equities | 55 | 7.86% | 171.52M | Nov 2018 | DOCG.L vs LGUK.L | |
| L&G Quality Equity Dividends ESG Exclusions UK UCI... | Europe Equities | 31 | 4.65% | 68.80M | Apr 2021 | DOCG.L vs LDUK.L |
Often Compared With DOCG.L
Investors most often compare DOCG.L with DRDR.L, VBR, SWDA.L. These 8 comparison targets span 5 categories, based on PortfoliosLab usage data.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | AUM | Inception | |
|---|---|---|---|---|---|---|---|
| iShares Healthcare Innovation UCITS ETF USD (Acc) | Health & Biotech Equities | 55 | 6.01% | 756.70M | Sep 2016 | DOCG.L vs DRDR.L | |
| Vanguard Small-Cap Value ETF | Small Cap Value Equities | 68 | 15.13% | 65.50B | Jan 2004 | DOCG.L vs VBR | |
| iShares Core MSCI World UCITS ETF USD (Acc) | Global Equities | 86 | 9.76% | 106.63B | Sep 2009 | DOCG.L vs SWDA.L | |
| The Biotech Growth Trust plc | 97 | 25.00% | — | — | DOCG.L vs BIOG.L | ||
| Lyxor UCITS MSCI World Health Care TR C-USD | Health & Biotech Equities | 33 | 0.01% | 897.02M | Aug 2010 | DOCG.L vs HLTW.L | |
| Invesco S&P World Health Care ESG UCITS ETF Acc | Health & Biotech Equities | 24 | -3.92% | — | Apr 2023 | DOCG.L vs WHCE.L | |
| L&G Russell 2000 US Small Cap UCITS ETF | Small Cap Blend Equities | 89 | 22.39% | 156.91M | Sep 2008 | DOCG.L vs RTWP.L | |
| L&G US Equity UCITS ETF | Large Cap Blend Equities | 76 | 9.40% | 1.09B | Nov 2018 | DOCG.L vs LGUG.L |
Compare DOCG.L with Any Fund or Stock
Compare DOCG.L with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.
Pair DOCG.L with funds that move differently
L&G Healthcare Breakthrough UCITS ETF alternatives help with substitution. Diversifiers are the next step when you want funds with lower historical correlation to DOCG.L.
Explore DOCG.L Diversifiers